p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
Douglas V. Faget(Heron Therapeutics (United States)), Sheila A. Stewart(Washington University in St. Louis)
Cited by 18
Related Papers
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
|Nature Communications|2016|471
Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression
|Cancer Research|2012|190
Osteopontin Stimulates Preneoplastic Cellular Proliferation Through Activation of the MAPK Pathway
|Molecular Cancer Research|2011|59
Flap Endonuclease 1 Limits Telomere Fragility on the Leading Strand
|Journal of Biological Chemistry|2015|37